Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
21 Mar 22
Current reports
8-K
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
27 Mar 24
8-K
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
26 Feb 24
8-K
Entry into a Material Definitive Agreement
21 Feb 24
8-K
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference
8 Jan 24
8-K
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
3 Jan 24
8-K
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
29 Dec 23
8-K
Departure of Directors or Certain Officers
15 Nov 23
8-K
STRATA Skin Sciences Reports Third Quarter 2023 Revenue
15 Nov 23
8-K
STRATA Skin Science Announces Leadership Change
30 Oct 23
8-K
STRATA Skin Sciences Reports Second Quarter 2023 Revenue
9 Aug 23
Registration and prospectus
S-3
Shelf registration
9 Aug 23
D
$480.21K in equity, sold $480.21K, 1 investor
20 Jan 22
S-3
Shelf registration
13 Jan 22
S-3/A
Shelf registration (amended)
22 Nov 21
S-3
Shelf registration
16 Nov 21
424B5
Prospectus supplement for primary offering
15 Oct 21
S-3/A
Shelf registration (amended)
12 Oct 21
S-3
Shelf registration
13 Aug 21
S-8
Registration of securities for employees
13 Jul 21
POS AM
Prospectus update (post-effective amendment)
21 Nov 19
Proxies
DEF 14A
Definitive proxy
25 Sep 23
PRE 14A
Preliminary proxy
12 Sep 23
DEF 14A
Definitive proxy
18 May 22
DEF 14A
Definitive proxy
2 Jun 21
DEF 14A
Definitive proxy
27 Nov 20
PRE 14A
Preliminary proxy
17 Nov 20
DEF 14A
Definitive proxy
27 Nov 19
DEF 14A
Definitive proxy
26 Nov 18
DEF 14A
Definitive proxy
27 Apr 18
PRE 14A
Preliminary proxy
17 Apr 18
Other
EFFECT
Notice of effectiveness
21 Aug 23
UPLOAD
Letter from SEC
16 Aug 23
CORRESP
Correspondence with SEC
16 Aug 23
EFFECT
Notice of effectiveness
25 Jan 22
CORRESP
Correspondence with SEC
19 Jan 22
UPLOAD
Letter from SEC
19 Jan 22
EFFECT
Notice of effectiveness
26 Nov 21
CORRESP
Correspondence with SEC
23 Nov 21
UPLOAD
Letter from SEC
19 Nov 21
EFFECT
Notice of effectiveness
18 Oct 21
Ownership